Skip to main content
Venus Medtech (Hangzhou) Inc. logo

Venus Medtech (Hangzhou) Inc. — Investor Relations & Filings

Ticker · 2500 ISIN · CNE100003PJ8 HKEX Manufacturing
Open in API
Filings indexed 363 across all filing types
Latest filing 2026-06-03 Share Issue/Capital Cha…
Country HK Hong Kong
Listing HKEX 2500

About Venus Medtech (Hangzhou) Inc.

http://www.venusmedtech.com

Venus Medtech (Hangzhou) Inc. is an innovation-driven medical device company specializing in the research, development, manufacturing, and commercialization of transcatheter solutions for structural heart diseases. The company focuses on bioprosthetic heart valves, establishing a comprehensive pipeline that addresses aortic, pulmonary, mitral, and tricuspid valve diseases. Its product portfolio includes transcatheter aortic valve replacement (TAVR) solutions, and it is committed to addressing unmet demand in TPVR and TMVR. The company also develops solutions for hypertension, such as renal artery denervation ablation, and related surgical accessory products. Its products are commercialized globally, reaching over 60 countries and regions across Asia, Europe, and the Americas.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 May 2026
Share Issue/Capital Change Classification · 90% confidence The document is the HKEX FF301 form titled “Monthly Return for Equity Issuer and Hong Kong Depositary Receipts… on Movements in Securities” for the month ended 31 May 2026. It details movements in authorised/registered share capital, issued and treasury shares, share options, repurchases, and other share capital changes under the Exchange Listing Rules. This is not an earnings release or management commentary, nor merely a publication notice; it is a mandatory listing disclosure covering new share issues, option grants, and share repurchases. Therefore it fits the Share Issue/Capital Change category (Code: SHA).
2026-06-03 English
PROXY FORM FOR USE AT THE 2025 ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 92% confidence The document is a proxy form for use at the 2025 Annual General Meeting, containing resolutions and instructions for shareholders to appoint proxies and vote. It is not the AGM presentation itself, nor the minutes or voting results, but rather materials sent to shareholders to solicit voting instructions. This fits the definition of a Proxy Solicitation & Information Statement (PSI).
2026-06-03 English
NOTICE OF 2025 ANNUAL GENERAL MEETING
AGM Information Classification · 98% confidence The document is a formal notice of the company’s upcoming 2025 Annual General Meeting (AGM), listing resolutions to be considered, voting arrangements, meeting date/time and procedural details. It does not contain financial statements or results but solely provides AGM logistics and agenda. This clearly matches the AGM Information category.
2026-06-03 English
(1) 2025 ANNUAL REPORT (2) WORK REPORT OF THE BOARD FOR 2025 (3) WORK REPORT OF THE SUPERVISORY COMMITTEE FOR 2025 (4) PROFIT DISTRIBUTION PLAN FOR 2025 (5) RE-APPOINTMENT OF AUDITORS FOR 2026 (6) GEN
Proxy Solicitation & Information Statement Classification · 93% confidence The document is a detailed circular to shareholders containing the notice of the 2025 Annual General Meeting, proxy form instructions, resolutions to be proposed, board work reports, explanatory statement, and proxy solicitation materials. It is not an actual annual report or financial statements, but rather the pre-meeting materials sent to shareholders to inform and solicit votes. This matches the definition of a Proxy Solicitation & Information Statement (PSI).
2026-06-03 English
Exchange's Disciplinary Action against Former Company Secretary of Venus Medtech (Hangzhou) Inc. (Stock Code: 2500)
Legal Proceedings Report Classification · 95% confidence The document is a detailed statement from the Stock Exchange of Hong Kong Limited regarding disciplinary action against a former company secretary of a listed company. It discusses breaches of listing rules, governance failures, and sanctions imposed on the individual. The content focuses on regulatory compliance, governance issues, and disciplinary measures rather than financial results, earnings, or capital changes. It is not an annual report, earnings release, or management report. It is also not a simple announcement or certification but a formal disciplinary report issued by a regulatory body. Therefore, the document fits best under the category of Legal Proceedings Report (LTR), as it details regulatory actions and sanctions related to governance and compliance breaches.
2026-05-19 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Board/Management Information Classification · 90% confidence The document is a formal announcement from Venus Medtech listing the company’s board of directors and their committee roles. It does not contain financial data, shareholder voting results, or refer to an attached report. It announces board composition and management roles, fitting the criteria for Board/Management Information.
2026-05-15 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.